Additionally it will be imperative to evaluate the mechanism cellular and genomic insults upregulate BRCA1-IRIS with, which could also be targeted to increase the ovarian cancer treatments efficacies in the clinic. Here, BRCA1 is linked to ovarian carcinoma.